Mycomune 500mg Tablet

Mycomune 500mg Tablet is an immunosuppressant containing mycophenolate mofetil as its active ingredient. It functions as an inosine monophosphate dehydrogenase (IMPDH) inhibitor. The medication is used to prevent organ rejection in patients who have received an organ transplant, including kidney, heart, or liver transplantation. Treatment is administered as part of combination therapy alongside other immunosuppressive medications.

This drug is contraindicated during pregnancy due to the risk of birth defects and miscarriage. It should not be prescribed in pregnant women unless no suitable alternatives exist and the potential benefits outweigh the risks. Women of childbearing potential are strongly advised to use effective contraception while taking this tablet to prevent pregnancy.

Live vaccines must not be administered to patients taking Mycomune 500mg Tablet due to reduced vaccine effectiveness and increased infection risk. Patients receiving this medication should not donate blood during treatment and for at least six weeks after discontinuation to ensure adequate clearance of the medication from the body.

The medicine should not be taken if you are allergic to mycophenolate mofetil or any other ingredients in the formulation. Inform your doctor of any existing liver or heart disease before commencing treatment. As this drug suppresses the body's immune defences, it increases the risk of skin cancer. Patients must take precautions to limit sunlight and ultraviolet (UV) light exposure.

Seek medical attention immediately if you develop unexplained bruising under the skin, fever, unexplained fatigue, dizziness, yellowing of the skin or eyes, vision changes, reduced urine output, or seizures after taking this medicine.

Mycomune 500mg Tablet is an immunosuppressive medication that may affect the infant's developing immune system and should be avoided during breastfeeding. In some cases, alternative medications with a more favourable safety profile during breastfeeding may be considered.

Prevent organ transplant rejections.

Mycomune 500mg Tablet works by inhibiting the enzyme inosine monophosphate dehydrogenase (IMPDH) and reducing the production of guanosine nucleotides. MMF specifically affects the proliferation of activated T and B lymphocytes. These lymphocytes are key players in the immune response that can lead to the rejection of a transplanted organ

It is an orally available prescription drug. Your physician will decide the dose and duration of the treatment based on your disease condition, severity, and other factors. Always take Mycomune 500mg Tablet as prescribed by your doctor. Do not open, crush, break, or chew the medicine.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Infections, fever, or sore throat Unusual bleeding or bruising Low blood cell count Severe allergic reactions Common Higher risk of developing lymphoma and other cancers Nausea, abdominal pain Diarrhea Constipation Loss of appetite Shortness of breath Weight loss Increased heartbeat Headache Blood pressure problem Anaemia

It is necessary to take the prescribed dose exactly as instructed by your doctor. Inform your doctor about all the medications (prescription, over-the-counter, and herbal) you are taking, as they can interact with this drug. If you plan to conceive or suspect you might be pregnant while taking Mycomune 500mg Tablet, it is important to consult your doctor immediately. They may suggest switching to alternative medications that are safer during pregnancy or adjusting your treatment plan.